Aligned Genetics, Inc. (KOSDAQ:238120)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,355.00
-45.00 (-1.32%)
At close: Oct 10, 2025
-1.32%
Market Cap47.80B
Revenue (ttm)17.17B
Net Income (ttm)3.32B
Shares Out14.06M
EPS (ttm)232.20
PE Ratio14.64
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume31,635
Average Volume23,554
Open3,420.00
Previous Close3,400.00
Day's Range3,340.00 - 3,420.00
52-Week Range2,575.00 - 4,200.00
Beta0.22
RSI51.99
Earnings DateNov 14, 2025

About Aligned Genetics

Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genetics, Inc. was founded in 2008 and is headquartered in Anyang-Si, South Korea. [Read more]

Industry Laboratory Analytical Instruments
Founded 2008
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 238120
Full Company Profile

Financial Performance

In 2024, Aligned Genetics's revenue was 15.78 billion, an increase of 3.70% compared to the previous year's 15.21 billion. Earnings were 4.13 billion, an increase of 27.57%.

Financial Statements

News

There is no news available yet.